Report Detail
Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2025
- RnM3480342 |
- 31 May, 2019 |
- Global |
- 112 Pages |
- QYResearch |
- Pharma & Healthcare
Botanical drugs are those drugs which are derived from medicinal plants. Plant derived drugs are combination of botanical as well as other approved drugs that contains plant materials, synthetic and semi synthetic substances. Botanical drugs consist of vegetable material, algae and macroscopic fungi. They are used in treatment of various diseases, such as central nervous system disorders, cardiovascular diseases, infectious diseases and respiratory diseases. Botanical drugs are available in various forms, such as pills, tablets, capsules and injections. Botanical drugs, such as aescin, adoniside, atropine and berberine, are derived from plants. These drugs are used as an important component of traditional medicine and therapies, such as homeopathy and ayurvedic medicines. Some of the major classes of plant drugs are terpenes, steroids, glycosides and phenols.
Globally, increased usage of botanical drugs as an alternative to synthetic medicine and increasing prevalence of various chronic diseases are some of the major drivers for growth of botanical and plant derived drugs. In addition, low cost of botanical drugs and technological advancement in production procedure of botanical drugs are also supporting in growth of botanical and plant derived drugs market. However, stringent laws and regulations for approval of botanical drugs is a key restraint for botanical and plant derived drugs market.
Moreover, increasing number of mergers and acquisitions by manufacturing companies is a key trend for botanical and plant derived drugs market.
The global Botanical and Plant Derived Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Botanical and Plant Derived Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Botanical and Plant Derived Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Botanical and Plant Derived Drugs in these regions.
This research report categorizes the global Botanical and Plant Derived Drugs market by top players/brands, region, type and end user. This report also studies the global Botanical and Plant Derived Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Abott Laboratories
Bayer Healthcare
Bionova
Bristol Myers
Curapharm
Market size by Product
Tablets
Capsules
Pills
Injections
Market size by End User
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Drug Stores
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Botanical and Plant Derived Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Botanical and Plant Derived Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Botanical and Plant Derived Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Botanical and Plant Derived Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Botanical and Plant Derived Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Botanical and Plant Derived Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Study Coverage
- 1.1 Botanical and Plant Derived Drugs Product
- 1.2 Market Segments
- 1.3 Key Manufacturers Covered
- 1.4 Market by Type
- 1.4.1 Global Botanical and Plant Derived Drugs Market Size Growth Rate by Product
- 1.4.2 Tablets
- 1.4.3 Capsules
- 1.4.4 Pills
- 1.4.5 Injections
- 1.5 Market by End User
- 1.5.1 Global Botanical and Plant Derived Drugs Market Size Growth Rate by End User
- 1.5.2 Hospital Pharmacies
- 1.5.3 Retail Pharmacies
- 1.5.4 Online Pharmacies
- 1.5.5 Drug Stores
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Botanical and Plant Derived Drugs Market Size
- 2.1.1 Global Botanical and Plant Derived Drugs Revenue 2014-2025
- 2.1.2 Global Botanical and Plant Derived Drugs Sales 2014-2025
- 2.2 Botanical and Plant Derived Drugs Growth Rate by Regions
- 2.2.1 Global Botanical and Plant Derived Drugs Sales by Regions
- 2.2.2 Global Botanical and Plant Derived Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
- 3.1 Botanical and Plant Derived Drugs Sales by Manufacturers
- 3.1.1 Botanical and Plant Derived Drugs Sales by Manufacturers
- 3.1.2 Botanical and Plant Derived Drugs Sales Market Share by Manufacturers
- 3.1.3 Global Botanical and Plant Derived Drugs Market Concentration Ratio (CR5 and HHI)
- 3.2 Botanical and Plant Derived Drugs Revenue by Manufacturers
- 3.2.1 Botanical and Plant Derived Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Botanical and Plant Derived Drugs Revenue Share by Manufacturers (2014-2019)
- 3.3 Botanical and Plant Derived Drugs Price by Manufacturers
- 3.4 Botanical and Plant Derived Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Botanical and Plant Derived Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Botanical and Plant Derived Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Botanical and Plant Derived Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
- 4.1 Global Botanical and Plant Derived Drugs Sales by Product
- 4.2 Global Botanical and Plant Derived Drugs Revenue by Product
- 4.3 Botanical and Plant Derived Drugs Price by Product
5 Breakdown Data by End User
- 5.1 Overview
- 5.2 Global Botanical and Plant Derived Drugs Breakdown Data by End User
6 North America
- 6.1 North America Botanical and Plant Derived Drugs by Countries
- 6.1.1 North America Botanical and Plant Derived Drugs Sales by Countries
- 6.1.2 North America Botanical and Plant Derived Drugs Revenue by Countries
- 6.1.3 United States
- 6.1.4 Canada
- 6.1.5 Mexico
- 6.2 North America Botanical and Plant Derived Drugs by Product
- 6.3 North America Botanical and Plant Derived Drugs by End User
7 Europe
- 7.1 Europe Botanical and Plant Derived Drugs by Countries
- 7.1.1 Europe Botanical and Plant Derived Drugs Sales by Countries
- 7.1.2 Europe Botanical and Plant Derived Drugs Revenue by Countries
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 UK
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Botanical and Plant Derived Drugs by Product
- 7.3 Europe Botanical and Plant Derived Drugs by End User
8 Asia Pacific
- 8.1 Asia Pacific Botanical and Plant Derived Drugs by Countries
- 8.1.1 Asia Pacific Botanical and Plant Derived Drugs Sales by Countries
- 8.1.2 Asia Pacific Botanical and Plant Derived Drugs Revenue by Countries
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Indonesia
- 8.1.9 Malaysia
- 8.1.10 Philippines
- 8.1.11 Thailand
- 8.1.12 Vietnam
- 8.1.13 Singapore
- 8.2 Asia Pacific Botanical and Plant Derived Drugs by Product
- 8.3 Asia Pacific Botanical and Plant Derived Drugs by End User
9 Central & South America
- 9.1 Central & South America Botanical and Plant Derived Drugs by Countries
- 9.1.1 Central & South America Botanical and Plant Derived Drugs Sales by Countries
- 9.1.2 Central & South America Botanical and Plant Derived Drugs Revenue by Countries
- 9.1.3 Brazil
- 9.2 Central & South America Botanical and Plant Derived Drugs by Product
- 9.3 Central & South America Botanical and Plant Derived Drugs by End User
10 Middle East and Africa
- 10.1 Middle East and Africa Botanical and Plant Derived Drugs by Countries
- 10.1.1 Middle East and Africa Botanical and Plant Derived Drugs Sales by Countries
- 10.1.2 Middle East and Africa Botanical and Plant Derived Drugs Revenue by Countries
- 10.1.3 GCC Countries
- 10.1.4 Turkey
- 10.1.5 Egypt
- 10.1.6 South Africa
- 10.2 Middle East and Africa Botanical and Plant Derived Drugs by Product
- 10.3 Middle East and Africa Botanical and Plant Derived Drugs by End User
11 Company Profiles
- 11.1 Abott Laboratories
- 11.1.1 Abott Laboratories Company Details
- 11.1.2 Company Business Overview
- 11.1.3 Abott Laboratories Botanical and Plant Derived Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.1.4 Abott Laboratories Botanical and Plant Derived Drugs Products Offered
- 11.1.5 Abott Laboratories Recent Development
- 11.2 Bayer Healthcare
- 11.2.1 Bayer Healthcare Company Details
- 11.2.2 Company Business Overview
- 11.2.3 Bayer Healthcare Botanical and Plant Derived Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.2.4 Bayer Healthcare Botanical and Plant Derived Drugs Products Offered
- 11.2.5 Bayer Healthcare Recent Development
- 11.3 Bionova
- 11.3.1 Bionova Company Details
- 11.3.2 Company Business Overview
- 11.3.3 Bionova Botanical and Plant Derived Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.3.4 Bionova Botanical and Plant Derived Drugs Products Offered
- 11.3.5 Bionova Recent Development
- 11.4 Bristol Myers
- 11.4.1 Bristol Myers Company Details
- 11.4.2 Company Business Overview
- 11.4.3 Bristol Myers Botanical and Plant Derived Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.4.4 Bristol Myers Botanical and Plant Derived Drugs Products Offered
- 11.4.5 Bristol Myers Recent Development
- 11.5 Curapharm
- 11.5.1 Curapharm Company Details
- 11.5.2 Company Business Overview
- 11.5.3 Curapharm Botanical and Plant Derived Drugs Sales, Revenue and Gross Margin (2014-2019)
- 11.5.4 Curapharm Botanical and Plant Derived Drugs Products Offered
- 11.5.5 Curapharm Recent Development
12 Future Forecast
- 12.1 Botanical and Plant Derived Drugs Market Forecast by Regions
- 12.1.1 Global Botanical and Plant Derived Drugs Sales Forecast by Regions 2019-2025
- 12.1.2 Global Botanical and Plant Derived Drugs Revenue Forecast by Regions 2019-2025
- 12.2 Botanical and Plant Derived Drugs Market Forecast by Product
- 12.2.1 Global Botanical and Plant Derived Drugs Sales Forecast by Product 2019-2025
- 12.2.2 Global Botanical and Plant Derived Drugs Revenue Forecast by Product 2019-2025
- 12.3 Botanical and Plant Derived Drugs Market Forecast by End User
- 12.4 North America Botanical and Plant Derived Drugs Forecast
- 12.5 Europe Botanical and Plant Derived Drugs Forecast
- 12.6 Asia Pacific Botanical and Plant Derived Drugs Forecast
- 12.7 Central & South America Botanical and Plant Derived Drugs Forecast
- 12.8 Middle East and Africa Botanical and Plant Derived Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Botanical and Plant Derived Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Botanical and Plant Derived Drugs . Industry analysis & Market Report on Botanical and Plant Derived Drugs is a syndicated market report, published as Global Botanical and Plant Derived Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Botanical and Plant Derived Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
